375 related articles for article (PubMed ID: 26855057)
41. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome.
Karow A; Steinemann D; Göhring G; Hasle H; Greiner J; Harila-Saari A; Flotho C; Zenker M; Schlegelberger B; Niemeyer CM; Kratz CP
Leukemia; 2007 Jun; 21(6):1303-5. PubMed ID: 17361219
[No Abstract] [Full Text] [Related]
42. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions.
Beneteau C; Cavé H; Moncla A; Dorison N; Munnich A; Verloes A; Leheup B
Eur J Hum Genet; 2009 Oct; 17(10):1216-21. PubMed ID: 19352411
[TBL] [Abstract][Full Text] [Related]
43. Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome.
Shoji Y; Ida S; Niihori T; Aoki Y; Okamoto N; Etani Y; Kawai M
Endocr J; 2019 Nov; 66(11):983-994. PubMed ID: 31292302
[TBL] [Abstract][Full Text] [Related]
44. Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7.
O'Halloran K; Ritchey AK; Djokic M; Friehling E
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28084675
[TBL] [Abstract][Full Text] [Related]
45. Comparative assessment of gene-specific variant distribution in prenatal and postnatal cohorts tested for Noonan syndrome and related conditions.
Leach NT; Wilson Mathews DR; Rosenblum LS; Zhou Z; Zhu H; Heim RA
Genet Med; 2019 Feb; 21(2):417-425. PubMed ID: 29907801
[TBL] [Abstract][Full Text] [Related]
46. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation.
Chantrain CF; Jijon P; De Raedt T; Vermylen C; Poirel HA; Legius E; Brichard B
Pediatr Blood Cancer; 2007 Jan; 48(1):101-4. PubMed ID: 16078230
[TBL] [Abstract][Full Text] [Related]
47. Expanding the genetic spectrum of Noonan syndrome.
Noordam K
Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
[TBL] [Abstract][Full Text] [Related]
48. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
Aljeaid D; Sanchez AI; Wakefield E; Chadwell SE; Moore N; Prada CE; Zhang W
Am J Med Genet A; 2019 Apr; 179(4):608-614. PubMed ID: 30762279
[TBL] [Abstract][Full Text] [Related]
50. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
Seemanová E; Zenker M
Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
[TBL] [Abstract][Full Text] [Related]
51. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
[TBL] [Abstract][Full Text] [Related]
52. Atrioventricular canal defect in patients with RASopathies.
Digilio MC; Romana Lepri F; Dentici ML; Henderson A; Baban A; Roberti MC; Capolino R; Versacci P; Surace C; Angioni A; Tartaglia M; Marino B; Dallapiccola B
Eur J Hum Genet; 2013 Feb; 21(2):200-4. PubMed ID: 22781091
[TBL] [Abstract][Full Text] [Related]
53. NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genes.
Ceyhan-Birsoy O; Miatkowski MM; Hynes E; Funke BH; Mason-Suares H
Hum Mutat; 2018 Jul; 39(7):954-958. PubMed ID: 29696744
[TBL] [Abstract][Full Text] [Related]
54. Childhood Rhabdomyosarcoma in Association With a RASopathy Clinical Phenotype and Mosaic Germline SOS1 Duplication.
Salem B; Hofherr S; Turner J; Doros L; Smpokou P
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e278-e282. PubMed ID: 27258033
[TBL] [Abstract][Full Text] [Related]
55. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
[TBL] [Abstract][Full Text] [Related]
56. Clinical and molecular analysis of 26 individuals with Noonan syndrome in a reference institution in Colombia.
Lores J; Prada CE; Ramírez-Montaño D; Nastasi-Catanese JA; Pachajoa H
Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):1042-1051. PubMed ID: 33300679
[TBL] [Abstract][Full Text] [Related]
57. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
Denayer E; Devriendt K; de Ravel T; Van Buggenhout G; Smeets E; Francois I; Sznajer Y; Craen M; Leventopoulos G; Mutesa L; Vandecasseye W; Massa G; Kayserili H; Sciot R; Fryns JP; Legius E
Genes Chromosomes Cancer; 2010 Mar; 49(3):242-52. PubMed ID: 19953625
[TBL] [Abstract][Full Text] [Related]
58. Common acute lymphoblastic leukemia in a girl with genetically confirmed LEOPARD syndrome.
Laux D; Kratz C; Sauerbrey A
J Pediatr Hematol Oncol; 2008 Aug; 30(8):602-4. PubMed ID: 18799937
[TBL] [Abstract][Full Text] [Related]
59. Hotspots in PTPN11 Gene Among Indian Children With Noonan Syndrome.
Narayanan DL; Pandey H; Moirangthem A; Mandal K; Gupta R; Puri RD; Patil SJ; Phadke SR
Indian Pediatr; 2017 Aug; 54(8):638-643. PubMed ID: 28607217
[TBL] [Abstract][Full Text] [Related]
60. Juvenile xanthogranuloma in Noonan syndrome.
Ali MM; Gilliam AE; Ruben BS; Tidyman WE; Rauen KA
Am J Med Genet A; 2021 Oct; 185(10):3048-3052. PubMed ID: 34032360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
